HOPX and neoplasm: HOPX can influence tissue repair and regeneration (76), and reduced HOPX expression (through promoter methylation) is associated with several cancers — e.g., colon (51), breast (79), thyroid, pancreas (80) — and metastasis risk — e.g., nasopharyngeal (81) — suggesting HOPX acts as a tumor suppressor.